Advantages of multi-arm non-randomised sequentially allocated cohort designs for Phase II oncology trials

Efficient trial designs are required to prioritise promising drugs within Phase II trials. Adaptive designs are examples of such designs, but their efficiency is reduced if there is a delay in assessing patient responses to treatment. Motivated by the WIRE trial in renal cell carcinoma (NCT03741426)...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of cancer Jg. 126; H. 2; S. 204 - 210
Hauptverfasser:	Mossop, Helen, Grayling, Michael J, Gallagher, Ferdia A, Welsh, Sarah J, Stewart, Grant D, Wason, James M S
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England Nature Publishing Group 01.02.2022
Schlagworte:	Adaptive Clinical Trials as Topic - methods Cancer therapies Clinical trials Clinical Trials, Phase II as Topic - methods Cohort Studies Computer Simulation - standards Efficiency Humans Hypotheses Kidney cancer Medical Oncology - methods Neoplasms - drug therapy Neoplasms - pathology Non-Randomized Controlled Trials as Topic - methods Oncology Patients Recruitment Renal cell carcinoma Research Design - standards Response rates Sample Size Simulation Surgery Treatment Outcome
ISSN:	0007-0920, 1532-1827, 1532-1827
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!